Clinical trial
Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
NCT00362323 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00362323 |
|---|---|
| Title | Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO |
| Official title | A Randomized, Double-blind Study Comparing the Efficacy and Safety of a Fixed Combination of Fenofibrate and Metformin vs Metformin Alone in Patients With Type 2 Diabetes Mellitus and Dyslipidemia Not Appropriately Controlled With a Statin. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyslipidemia/Glucose Metabolism Disorder |
| Intervention type | Drug |
| Interventions | fenofibrate (F) + metformin (M) hydrochloride fixed combination, Metformin |
| Enrollment | 482 |
| Start date | Oct 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Aug 10, 2006 |
| Last update posted | Apr 16, 2010 |
| Countries | Czechia, France, Hungary, India, Lithuania, Poland, Slovakia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: